When Mounjaro Stops Working: What's Actually Happening

Step 1: Recognise what a plateau actually means on tirzepatide

The most disheartening moment for many people on Mounjaro is opening the app, stepping on the scale, and seeing the same number as last week. After weeks of progress, that stillness feels like something has gone wrong. Often it hasn't.

When body weight falls, the body's energy requirements fall with it. Your basal metabolic rate (the calories your organs burn just keeping you alive) drops in proportion to how much mass you're carrying. This is physiology, not failure. The same calorie intake that produced a deficit at your starting weight may no longer produce one at your current weight. The medicine is still doing what it does; the target has shifted.

There's a second biological driver that's less talked about. As the weeks pass on a stable dose of tirzepatide, the appetite-suppressing signal can become less pronounced. If you're trying to understand whether tirzepatide can stop working and what drives that change, it helps to know that the body's sensitivity to GIP and GLP-1 receptor stimulation at a fixed concentration can shift over time. You may notice you're hungrier between doses, or that meals feel less obviously controlled. That signal matters and is worth noting before your next review.

The NHS tirzepatide medicines page notes that treatment is intended to sit alongside a reduced-calorie diet and increased activity, which is partly because these lifestyle factors become more important, not less, as the dose effect stabilises.

Step 2: Check the modifiable factors before assuming the medicine needs changing

Before concluding that Mounjaro has stopped working, a prescriber will want to understand what else has shifted. A few things are worth reflecting on honestly before that conversation.

Food choices often drift without people realising. The strong appetite suppression of the early weeks can mask how gradually portion sizes or snack frequency creep back up. A food diary kept for five to seven days (not as a punishment, just as data) frequently surprises people. Similarly, a long stretch of disrupted sleep, high work stress, or a period of reduced activity all have measurable effects on the hormones that govern hunger and fat storage.

Injection technique and rotation matter too. Injecting repeatedly into the same site can cause lipohypertrophy (a subtle thickening under the skin) which changes how reliably the medicine is absorbed. Rotating between the abdomen, thigh, and upper arm, as described in the Patient Information Leaflet, keeps absorption consistent.

Some medicines interact with tirzepatide's effect on gastric emptying; if you've started a new medication in the months since beginning Mounjaro, flag it to your prescriber. If you're also using hormonal contraception, our page on whether Mounjaro affects how the pill works is worth reading before your next review. Our frequently asked questions page covers some of the common interaction queries we receive.

It's also worth confirming you're storing the pen correctly. The KwikPen should be refrigerated; a pen left on a warm windowsill for longer than the SmPC permits may lose potency. Always check the leaflet (not a forum) for the exact storage window that applies to your pen.

Step 3: Understand how dose titration and prescriber review work in practice

The titration schedule for Mounjaro runs from 2.5mg through to 15mg, with the prescriber moving the dose up in 4-week steps. The early doses are there to let your system adjust comfortably; the higher doses are where the therapeutic weight-management effect tends to be strongest. NICE's appraisal of tirzepatide (TA1026) notes that continuing treatment is reviewed if weight loss falls below 5% after six months at the highest tolerated dose, which gives you a sense of what clinical guidance considers a meaningful signal versus an ordinary plateau.

If you're on a mid-range dose (5mg or 7.5mg, for instance) and progress has stalled, the most common clinical response is to move to the next step, provided you're tolerating the current dose well and there are no contraindications. That's not Mounjaro failing; that's the titration schedule working as designed.

For people already at 15mg who have plateaued, the conversation shifts. A prescriber would look at the full picture: how much weight has been lost overall, which lifestyle factors are in play, and whether any underlying condition (thyroid function, for example) might be interfering. There are circumstances where an extended pause and re-sensitisation is appropriate; there are others where the decision is that 15mg has produced its maximum effect for that person.

If you want a detailed look at whether Mounjaro does stop working and what the evidence says about long-term response, that page goes into the clinical picture thoroughly. And if you want to understand the broader picture of how tirzepatide works across a full course of treatment, the tirzepatide overview is a useful reference.

Step 4: Know when to raise it with your prescriber, and how

A plateau lasting two to three weeks on a stable dose is not, by itself, a clinical red flag. The body can stall for a fortnight and then resume moving. A plateau lasting six to eight weeks, especially at a dose that hasn't recently changed, is worth raising.

When you contact your prescriber about a plateau, the most useful things to bring to that conversation are: how many weeks progress has been flat, which dose you're currently on, whether your appetite suppression feels the same or diminished, and any changes in lifestyle, sleep, stress or medication since the plateau began. That information lets the prescriber make a genuinely useful assessment rather than a speculative one.

Some people find it helpful to have this conversation around a repeat order, our prescribers review every repeat clinically (there are no auto-renewals), so that's a natural checkpoint. If you'd rather ask a specific question between orders, the support team can help you get it in front of the right person quickly.

Treatment cost is sometimes a factor in how people approach these conversations. If you're weighing whether continuing at a higher dose makes financial sense, the Mounjaro price comparison guide explains what private treatment costs across the UK and what legitimate pricing typically includes. That context can make the decision feel less opaque. For a broader look at weight-management options alongside tirzepatide, the weight-loss treatment overview is worth a read.

The short version: our page on what to do when Mounjaro stops working covers the practical steps in full, because stopping working in the absolute sense is less common than a plateau that has a fixable cause. A prescriber is the right person to tell the difference. At the end of that conversation, you'll have a clearer plan, not just a number on a scale.